A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Status:
Recruiting

Trial end date:
2029-03-16

Target enrollment:

Participant gender:

This study aims to evaluate the efficacy and safety of crovalimab in pediatric participants with aHUS.

Phase 3

Hoffmann-La Roche

Chugai Pharmaceutical